Vancomycin-resistant Staphylococcus aureus (VRSA) in hepatic cirrhosis patient: a case report

被引：3
作者：
Ramazoni, M. [1 ]
Siregar, M. L. [2 ]
Jamil, K. F. [2 ]
机构：
[1] Syiah Kuala Univ, Med Sch, Banda Aceh, Indonesia
[2] Syiah Kuala Univ, Dr Zainoel Abidin Hosp, Med Sch, Dept Internal Med,Div Trop & Infect Dis, Banda Aceh 23126, Indonesia
来源：
1ST INT CONF ON TROP MED & INFECT DIS FAC OF MED UNIV SUMATERA UTARA IN CONJUNCTION WITH THE 23RD NATL CONGRESS OF THE INDONESIAN SOC OF TROP & INFECT DIS CONSULTANT AND THE 18TH ANNUAL MEETING OF INTERNAL MED DEPT FAC OF MED UNIV SUMATERA UTARA | 2018年 / 125卷
关键词：
RISK-FACTORS; PREVALENCE;
D O I：
10.1088/1755-1315/125/1/012096
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
The irrational use of vancomycin in methicillin-resistant Staphylococcus aureus (MRSA) infections result in the emergence of vancomycin-resistant Staphylococcus aureus (VRSA) pathogen, which can pose a threat to the world healthcare. A 32-year-old male with hepatic cirrhosis patient admitted with recurrent gastrointestinal bleeding with a wound in his left leg since 6 months ago; the result microbiological culture showed a VRSA with minimum inhibitory concentration (MIC) vancomycin >= 32 mu g/mL. The patient was treated with trimethoprim/sulfamethoxazole combination according to cultural sensitivity. The second microbiological culture showed thesame result. VRSA is a rare and difficult condition to handle. The success of therapy for this VRSA case warn us how important to cut the S. aureus distribution chain with a high level of resistance.
引用
收藏
页数：3
相关论文
共 11 条
  • [1] Prevalence of and Risk Factors for Vancomycin-Resistant Staphylococcus aureus Precursor Organisms in Southeastern Michigan
    Albrecht, Valerie S.
    Zervos, Marcus J.
    Kaye, Keith S.
    Tosh, Pritish K.
    Arshad, Samia
    Hayakawa, Kayoko
    Kallen, Alexander J.
    McDougal, Linda K.
    Limbago, Brandi M.
    Guh, Alice Y.
    [J]. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2014, 35 (12) : 1531 - 1534
  • [2] Vancomycin bound biogenic gold nanoparticles: A different perspective for development of anti VRSA agents
    Fayaz, A. Mohammed
    Girilal, M.
    Mandy, Saba A.
    Somsundar, S. S.
    Venkatesan, R.
    Kalaichelvan, P. T.
    [J]. PROCESS BIOCHEMISTRY, 2011, 46 (03) : 636 - 641
  • [3] Mechanisms of vancomycin resistance in Staphylococcus aureus
    Gardete, Susana
    Tomasz, Alexander
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2014, 124 (07) : 2836 - 2840
  • [4] Treatment of bacteraemia: meticillin-resistant Staphylococcus aureus (MRSA) to vancomycin-resistant S. aureus (VRSA)
    Gould, I. M.
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2013, 42 : S17 - S21
  • [5] Relationship between Vancomycin-Resistant Staphylococcus aureus, Vancomycin-Intermediate S. aureus, High Vancomycin MIC, and Outcome in Serious S. aureus Infections
    Holmes, Natasha E.
    Johnson, Paul D. R.
    Howden, Benjamin P.
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2012, 50 (08) : 2548 - 2552
  • [6] Report of the 13th Vancomycin-Resistant Staphylococcus aureus Isolate from the United States
    Limbago, Brandi M.
    Kallen, Alexander J.
    Zhu, Wenming
    Eggers, Paula
    McDougal, Linda K.
    Albrecht, Valerie S.
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2014, 52 (03) : 998 - 1002
  • [7] Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus Aureus Infections in Adults and Children
    Liu, Catherine
    Bayer, Arnold
    Cosgrove, Sara E.
    Daum, Robert S.
    Fridkin, Scott K.
    Gorwitz, Rachel J.
    Kaplan, Sheldon L.
    Karchmer, Adolf W.
    Levine, Donald P.
    Murray, Barbara E.
    Rybak, Michael J.
    Talan, David A.
    Chambers, Henry F.
    [J]. CLINICAL INFECTIOUS DISEASES, 2011, 52 (03) : E18 - E55
  • [8] Loomba P, 2010, J GLOBAL INFECT DIS, V2
  • [9] Thati Venubabu, 2011, Indian J Med Res, V134, P704, DOI 10.4103/0971-5916.91001
  • [10] Prevalence and Risk Factors Associated with Vancomycin-Resistant Staphylococcus aureus Precursor Organism Colonization among Patients with Chronic Lower-Extremity Wounds in Southeastern Michigan
    Tosh, Pritish K.
    Agolory, Simon
    Strong, Bethany L.
    VerLee, Kerrie
    Finks, Jennie
    Hayakawa, Kayoko
    Chopra, Teena
    Kaye, Keith S.
    Gilpin, Nicholas
    Carpenter, Christopher F.
    Haque, Nadia Z.
    Lamarato, Lois E.
    Zervos, Marcus J.
    Albrecht, Valerie S.
    McAllister, Sigrid K.
    Limbago, Brandi
    MacCannell, Duncan R.
    McDougal, Linda K.
    Kallen, Alexander J.
    Guh, Alice Y.
    [J]. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2013, 34 (09) : 954 - 960
12